Eris Lifesciences Q1 Review - Steady Outperformance Across Major Therapies: Motilal Oswal
1 week ago•Bloomberg Quint
Eris Lifesciences enters licensing deal with Biocon for insulin glargine
1 week ago•Economic Times
Buy Eris Lifesciences; target of Rs 870: Motilal Oswal
2 months ago•Moneycontrol
Eris Lifesciences - Niche Launches To Aid Growth Over The Medium Term: Motilal Oswal
3 months ago•Bloomberg Quint
Eris Lifesciences Q4 Review - New Launches Scale-Up Holds Key: Prabhudas Lilladher
3 months ago•Bloomberg Quint
Buy Eris Lifesciences; target of Rs 870: Motilal Oswal
3 months ago•Moneycontrol
Buy Eris Lifesciences; target of Rs 850: Prabhudas Lilladher
3 months ago•Moneycontrol
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is more than the intrinsic value